Translation and Psychometric Properties of the Fatigue Severity Scale in Patients With Fibromyalgia
NCT ID: NCT06031207
Last Updated: 2025-08-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2023-09-01
2024-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The anticipated duration of the study will be 09 months, commencing after the approval of the synopsis.
The sample size will be determined following the Kline Method, resulting in a total of 90 participants.
A Purposive Sampling Technique will be utilized to select the study participants.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Fibromyalgia Syndrome Accompanying Obstructive Sleep Apnea Syndrome on Clinical Findings
NCT05367167
Pain Phenotypes in Patients with Fibromyalgia Syndrome
NCT05941780
Supervised and Home Training in Fibromyalgia
NCT06956456
Effectiveness of Strength Training Versus Flexibility Training in Patients With Fibromyalgia
NCT05542225
Dual Task in Female Patients With Fibromyalgia
NCT05210751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Translation of FSS:
The Fatigue Severity Scale (FSS) will be translated into Urdu for data collection.
Two independent bilingual translators will create reports on translation difficulties and rationale.
These reports will inform a consensus meeting to develop a unified Urdu version, with comments documented.
The unified version will be backtranslated into English by native English-speaking translators unaware of the questionnaire's concept.
Expert Committee:
An expert committee comprising physical therapists, linguists, and a methodologist will review both language versions.
The goal is to ensure semantic, idiomatic, experiential, and conceptual equivalence and reach consensus on the final Urdu version of the FSS.
Patient Involvement:
The final Urdu FSS version will be administered to 20 fibromyalgia patients. These patients will also be interviewed to assess their understanding of questionnaire items.
Participants will receive additional information about fibromyalgia to prevent confusion.
Data Collection:
Data will be collected from 100 fibromyalgia patients using the final Urdu FSS version.
A retest will be conducted after 48 hours.
Additional Assessment:
All 90 participants will complete the Multidimensional Fatigue Inventory (MFI).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed and referred patients of fibromyalgia according to the American College of Rheumatology (ACR) criteria.
* The ability to provide informed consent and wiling to participate in the study.
* Fluency in the study language (i.e. Urdu in this case).
Exclusion Criteria
* Diagnosed sleep disorder (such as sleep apnea or insomnia) that could affect the results.
* History of a psychiatric disorder that could affect the results.
* History of substance abuse.
* Participation in any other study that could affect the results at the time of recruitment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Memona Khan, MSPT MSK*
Role: PRINCIPAL_INVESTIGATOR
University of Lahore
Hafiza Sana Ashraf, MSPT MSK
Role: STUDY_DIRECTOR
University of Lahore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Lahore Teaching Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-UOL-492-08-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.